A model for the relative biological effectiveness of protons: The tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes

Abstract Background. The biological effects of particles are often expressed in relation to that of photons through the concept of relative biological effectiveness, RBE. In proton radiotherapy, a constant RBE of 1.1 is usually assumed. However, there is experimental evidence that RBE depends on various factors. The aim of this study is to develop a model to predict the RBE based on linear energy transfer (LET), dose, and the tissue specific parameter α/β of the linear-quadratic model for the reference radiation. Moreover, the model should capture the basic features of the RBE using a minimum of assumptions, each supported by experimental data. Material and methods. The α and β parameters for protons were studied with respect to their dependence on LET. An RBE model was proposed where the dependence of LET is affected by the (α/β)phot ratio of photons. Published cell survival data with a range of well-defined LETs and cell types were selected for model evaluation rendering a total of 10 cell lines and 24 RBE values. Results and Conclusion. A statistically significant relation was found between α for protons and LET. Moreover, the strength of that relation varied significantly with (α/β)phot. In contrast, no significant relation between β and LET was found. On the whole, the resulting RBE model provided a significantly improved fit (p-value < 0.01) to the experimental data compared to the standard constant RBE. By accounting for the α/β ratio of photons, clearer trends between RBE and LET of protons were found, and our results suggest that late responding tissues are more sensitive to LET changes than early responding tissues and most tumors. An advantage with the proposed RBE model in optimization and evaluation of treatment plans is that it only requires dose, LET, and (α/β)phot as input parameters. Hence, no proton specific biological parameters are needed.

[1]  F Ianzini,et al.  RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facility. , 1998, International journal of radiation biology.

[2]  M. Cavinato,et al.  Relative biological effectiveness of light ions in human tumoural cell lines: role of protein p53. , 2002, Radiation protection dosimetry.

[3]  B. Jones,et al.  Particle Therapy Co-operative Oncology Group (PTCOG 40) meeting, Institute Curie 2004. , 2005, The British journal of radiology.

[4]  R. Marchesini,et al.  Inactivation of C3H10T1/2 cells by low energy protons and deuterons. , 1998, International journal of radiation biology.

[5]  E Grusell,et al.  Relative biological effectiveness of intermediate energy protons. Comparisons with 60Co gamma-radiation using two cell lines. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  R. Hawkins.  A microdosimetric-kinetic theory of the dependence of the RBE for cell death on LET. , 1998, Medical physics.

[7]  V Grégoire,et al.  Measurements of radiobiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvain-la-Neuve, Belgium. , 1996, Radiation research.

[8]  H. Tsujii,et al.  ICRU Report No. 78, Prescribing, recording, and reporting proton-beam therapy. , 2007 .

[9]  T. Delaney,et al.  Prescribing, Recording, and Reporting Proton-Beam Therapy , 2009 .

[10]  M Pugliese,et al.  Inactivation of human normal and tumour cells irradiated with low energy protons. , 2000, International journal of radiation biology.

[11]  A. Antoccia,et al.  Micronuclei, CREST-positive micronuclei and cell inactivation induced in Chinese hamster cells by radiation with different quality. , 2000, International journal of radiation biology.

[12]  David J Carlson,et al.  A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[13]  U Oelfke,et al.  A phenomenological model for the relative biological effectiveness in therapeutic proton beams. , 2004, Physics in medicine and biology.

[14]  E. Sideris,et al.  Biological effectiveness of low energy protons. I. Survival of Chinese hamster cells. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[15]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[16]  W. K. Sinclair.  THE SHAPE OF RADIATION SURVIVAL CURVES OF CULTURED MAMMALIAN CELLS IN VITRO. , 1967 .

[17]  K M Prise,et al.  Inactivation of V79 cells by low-energy protons, deuterons and helium-3 ions. , 1996, International journal of radiation biology.

[18]  L. Gerweck,et al.  Relative biological effectiveness of proton beams in clinical therapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Harald Paganetti,et al.  Range uncertainty in proton therapy due to variable biological effectiveness. , 2012, Physics in medicine and biology.

[20]  U. Isacsson,et al.  The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer , 2005, Physics in medicine and biology.

[21]  R. Marchesini,et al.  Radiobiological studies on the 65 MeV therapeutic proton beam at Nice using human tumour cells. , 2000, International journal of radiation biology.

[22]  R. Dale,et al.  The assessment of RBE effects using the concept of biologically effective dose. , 1999, International journal of radiation oncology, biology, physics.